KEY POINTS
- A former NHS chief executive says patients are endangered by “sham investigations” used to silence staff who raise safety concerns.
- A landmark tribunal recently awarded Dr. Susan Gilby £1.4 million after finding she was unfairly forced out of her role.
- Senior leaders allegedly conspired to build a false case and destroy evidence to engineer the dismissal of the whistleblower.
NHS patient safety is being compromised by a leadership culture that uses false investigations to suppress whistleblowers. This warning comes from Dr. Susan Gilby, the former chief executive of the Countess of Chester Hospital. Speaking after a landmark legal victory, she described how senior managers launch manufactured misconduct probes to shut down legitimate concerns. These “sham investigations” reportedly create a climate of fear that stops doctors from reporting errors.
Last month, an employment tribunal awarded Dr. Gilby £1.4 million in damages, one of the largest settlements in NHS history. The judges ruled that she had been unfairly dismissed and subjected to detrimental treatment. Dr. Gilby had raised protected disclosures regarding the aggressive and bullying behavior of the trust’s then-chairman. Instead of addressing her claims, senior figures allegedly collaborated on a secret plan codenamed “Project Countess” to remove her.
The tribunal findings exposed a coordinated effort to fabricate performance issues against Dr. Gilby. The judge noted that senior leaders intentionally withheld or deleted key documents, including emails and WhatsApp messages. This destruction of evidence aimed to mask the “behind-the-scenes machinations” used to engineer her exit. The court described the trust’s conduct as an attempt to protect the organization’s reputation over the truth.
Dr. Gilby told reporters that being a whistleblower made her feel like a “pariah” within the healthcare system. She revealed that she was offered a “non-job” elsewhere in the NHS on the condition she drop her complaints. Refusing to compromise her integrity, she pursued the legal battle to highlight systemic failures in healthcare governance. She now warns that such tactics are “not just one bad apple” but a widespread issue.
The British Medical Association has condemned the treatment of Dr. Gilby as “nothing short of disgraceful.” The association is calling for the urgent regulation of senior NHS managers from non-clinical backgrounds. Currently, these leaders do not face the same professional accountability as doctors or nurses. Advocates argue that without legal frameworks for management, patient safety incidents will continue to go unnoticed and unreported.
The total cost to the taxpayer for this case is estimated to exceed £3 million, including legal fees. Despite the significant payout, Dr. Gilby expressed sadness over the needless end of her 32-year medical career. She urged the government to reform whistleblowing laws to ensure they are fit for purpose. For now, the case serves as a stark reminder of the personal and financial costs of silencing dissent in public health.
